Shuwen Biotech collaborates with PerkinElmer

Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced that PerkinElmer, Inc. will distribute...

February 26, 2020 | Wednesday | News
Clover, GSK announce research collaboration for COVID-19 vaccine

Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and tra...

February 25, 2020 | Tuesday | News
FedEx delivers urgent medical supplies to China

FedEx Express (FedEx),  world’s largest express transportation company, has donated the use of its extensive ...

February 24, 2020 | Monday | News
Lilly Veteran to Head Everest Medicine

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...

February 24, 2020 | Monday | News
WuXi Biologics congratulates Immutep on positive interim data for IMP-321

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 24, 2020 | Monday | News
Chengdu medical city set to create new waves

In 2019, with the continuous advancement of "three medical integration", China's Chengdu Medical City's three medical in...

February 24, 2020 | Monday | News
S-CELL collaborates with Chronomics for preventive healthcare

Hong Kong based S-CELL, in partnership with Chronomics, is the first company in Asia to introduce Healthspan, ...

February 21, 2020 | Friday | News
Vifor Pharma, Fresenius Kabi create joint venture in China for i.v. iron portfolio

Vifor Pharma has announced a strategic partnership with Fresenius Kabi to create a new joint company based in the People...

February 20, 2020 | Thursday | News
YITU AI Aids Epidemic Prevention and Control of Coronavirus

On February 4th, Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectiou...

February 20, 2020 | Thursday | News
DNX Biopharma connects with Lung Cancer Initiative at J&J

US based DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatme...

February 20, 2020 | Thursday | News
Chinese S&T Ministry launches programme to tackle COVID-19

As to the battle against the COVID-19, Chinese Ministry of Science and Technology (MOST) has launched the prog...

February 19, 2020 | Wednesday | News
WuXi Vaccines to build integrated manufacturing facility

WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...

February 18, 2020 | Tuesday | News
WeSure launches coronavirus pneumonia insurance

Following the 2019 novel coronavirus outbreak ("Covid-19"), WeSure, Tencent's insurance platform, swiftly established an...

February 17, 2020 | Monday | News
Hua Medicine appoints former U.S. FDA Officer as CTO

Hua Medicine, a leading clinical stage biotechnology company based in Shanghai,has announced Dr. Fuxing Tang has joined ...

February 17, 2020 | Monday | News
Mathematical model indicates decline in current novel coronavirus infections in China

A mathematical model set up by an ad-hoc group of scientists indicates the number of currently infected novel coronaviru...

February 17, 2020 | Monday | News
PolyU develops most comprehensive multiplex diagnostic system

Infectious diseases represent an important portion of global public health concerns¸ in particular with regard to ...

February 14, 2020 | Friday | News
China's Borui Biomedical imitates Gilead's Coronavirus drug

Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...

February 14, 2020 | Friday | News
WuXi Biologics Wuhan Site Resumes Operations

WuXi Biologics is closely monitoring the coronavirus outbreak.  The firm said its management team is working vigila...

February 14, 2020 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls